Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Symtuza® (darunavir, cobicistat, emtricitabine, tenofovir alafenamide) | Janssen Therapeutics | ||
| Synagis® (palivizumab) | Sobi | ||
| Synagis® (palivizumab) North Carolina | Medimmune, Inc. | ||
| Synvisc® (hylan G-F 20) |
Osteoarthritis
|
Genzyme Corporation | |
| Synvisc-One® (hylan G-F 20) |
Osteoarthritis
|
Genzyme Corporation | |
| Tabrecta™ (capmatinib) | Novartis Pharmaceuticals Corp. | ||
| Tadliq® (Tadalafil) | CMP Pharma | ||
| Tafinlar® (dabrafenib) | Novartis Pharmaceuticals Corp. | ||
| Tagrisso® (osimertinib) |
Lung cancer
|
AstraZeneca | |
| Takhzyro™ (lanadelumab-flyo) | Takeda Pharmaceuticals |